D3A.011
Benign carcinoid tumor of the jejunum
Clinical Classification Guidelines
Medical Intelligence & Overview
A benign carcinoid tumor of the jejunum is a non-cancerous growth that develops in the jejunum, which is the middle section of the small intestine. These tumors originate from neuroendocrine cells, which produce hormones and help regulate various bodily functions. Although benign, these tumors require medical monitoring and, in some cases, treatment to prevent complications. Understanding the nature, causes, symptoms, and management options can help patients better navigate their health journey when diagnosed with this condition.
Causes & Symptoms
Clinical Causes: Genetic factors that may predispose some individuals to develop neuroendocrine tumors Mutations in specific genes affecting cell growth and division Certain hereditary syndromes, such as Multiple Endocrine Neoplasia (MEN) syndromes Environmental factors or exposure to certain chemicals, though these are less clearly established
Key Symptoms: Often asymptomatic, especially in early stages Digestive issues like nausea, diarrhea, or abdominal discomfort Unexplained weight loss or fatigue in some cases Palpable mass or swelling if the tumor grows large enough Occasional bleeding leading to anemia
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a combination of medical history review, physical examinations, and specialized tests. Diagnostic procedures may include:
Treatment Protocols: Management of a benign carcinoid tumor depends on the size, location, and whether it has caused any complications. Common treatment approaches include:
Clinical Advice & FAQs
Billing Guidance
Is D3A.011 a billable ICD-10 code?
Yes, D3A.011 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D3A.011?
Clinical documentation must specify the nature of Benign carcinoid tumor of the jejunum and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
